AN2 Therapeutics Ownership | Who Owns AN2 Therapeutics?

AN2 Therapeutics Ownership Summary

AN2 Therapeutics is owned by 55.07% institutional investors, 18.13% insiders, and 26.81% retail investors. Vivo capital is the largest institutional shareholder, holding 10.44% of ANTX shares. Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund, with 2.37% of its assets in AN2 Therapeutics shares.

ANTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	AN2 Therapeutics	55.07%	18.13%	26.81%
Sector	Healthcare Stocks	245.07%	12.10%	-157.17%
Industry	Biotech Stocks	380.48%	11.73%	-292.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vivo capital	3.15M	10.44%	$10.79M
Commodore capital lp	2.33M	7.72%	$7.98M
Millennium management	2.22M	7.36%	$7.60M
Almitas capital	1.48M	4.90%	$5.06M
Vanguard group	1.08M	3.57%	$1.23M
Adage capital partners gp	1.00M	3.31%	$3.42M
Woodline partners lp	993.67K	3.29%	$3.40M
Boxer capital management	749.03K	2.48%	$2.56M
Stonepine capital management	713.85K	2.36%	$2.44M
Ameriprise financial	696.18K	2.30%	$2.38M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Almitas capital	1.48M	1.14%	$5.06M
Stonepine capital management	713.85K	0.98%	$2.44M
Vivo capital	3.15M	0.90%	$10.79M
Commodore capital lp	2.33M	0.46%	$7.98M
Boxer capital management	749.03K	0.34%	$2.56M
Sio capital management	657.20K	0.32%	$2.25M
Prosight management, lp	515.75K	0.29%	$1.76M
Landscape capital management	298.17K	0.06%	$1.02M
Woodline partners lp	993.67K	0.01%	$3.40M
Adage capital partners gp	1.00M	0.01%	$3.42M

Top Buyers

Holder	Shares	% Assets	Change
Vivo capital	3.15M	0.90%	3.15M
Commodore capital lp	2.33M	0.46%	2.33M
Millennium management	2.22M	0.00%	2.13M
Adage capital partners gp	1.00M	0.01%	1.00M
Woodline partners lp	993.67K	0.01%	847.70K

Top Sellers

Holder	Shares	% Assets	Change
Bml capital management	-	-	-5.75M
Octagon capital advisors lp	-	-	-3.22M
Frazier life sciences management	-	-	-2.09M
Ra capital management	-	-	-2.00M
Tcg crossover management	-	-	-1.56M

New Positions

Holder	Shares	% Assets	Change	Value
Vivo capital	3.15M	0.90%	3.15M	$10.79M
Commodore capital lp	2.33M	0.46%	2.33M	$7.98M
Adage capital partners gp	1.00M	0.01%	1.00M	$3.42M
Boxer capital management	749.03K	0.34%	749.03K	$2.56M
Ameriprise financial	696.18K	0.00%	696.18K	$2.38M

Sold Out

Holder	Change
Jpmorgan chase	-49.00
Wells fargo & company/mn	-128.00
Coldstream capital management	-783.00
Fmr	-1.20K
Highline wealth partners	-5.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	67	28.85%	24,648,255	12.58%	55	1.33%	44	15.79%	14	75.00%
Mar 31, 2026	11	-70.27%	1,358,232	-84.32%	4	0.55%	8	-42.86%	3	-62.50%
Dec 31, 2025	17	-51.43%	4,827,731	-41.67%	15	2.13%	7	-22.22%	4	-63.64%
Sep 30, 2025	34	-	8,236,317	1.76%	27	3.79%	9	-40.00%	11	120.00%
Jun 30, 2025	36	-	8,284,557	-36.41%	27	1.46%	17	30.77%	5	-54.55%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Morn Total Stk Mkt Idx Investor	853.02K	2.37%	119.63K
Vanguard Total Stock Mkt Idx Inv	853.02K	2.37%	119.63K
Vanguard MStar Total Stk Mkt Idx Invest	853.02K	2.26%	-
iShares Russell 2000 ETF	670.09K	1.78%	-7.74K
MEDICAL BioHealth EUR Acc	632.33K	1.68%	134.00
Vanguard Institutional Extnd Mkt Idx Tr	360.11K	0.99%	-
apo Medical Opportunities R	330.55K	0.88%	-
Fidelity Small Cap Index	289.23K	0.77%	2.12K
iShares Russell 2000 Value ETF	194.14K	0.51%	-
Russell 2000 Index Non-Lendable Fund	169.79K	0.47%	169.79K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 09, 2026	Readnour Robin Shane	-	Sell	$3.15K
Sep 09, 2026	Readnour Robin Shane	-	Sell	$3.52K
Sep 03, 2026	Readnour Robin Shane	-	Sell	$17.46K
Sep 03, 2026	Readnour Robin Shane	-	Sell	$19.56K
Sep 08, 2026	Readnour Robin Shane	-	Sell	$31.86K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	1	10
2026 Q2	-	1
2026 Q1	-	9
2025 Q4	-	2
2025 Q3	-	-

ANTX Ownership FAQ

Who Owns AN2 Therapeutics?

AN2 Therapeutics shareholders are primarily institutional investors at 55.07%, followed by 18.13% insiders and 26.80% retail investors. The average institutional ownership in AN2 Therapeutics's industry, Biotech Stocks , is 380.48%, which AN2 Therapeutics falls below.

Who owns the most shares of AN2 Therapeutics?

AN2 Therapeutics’s largest shareholders are Vivo capital (3.15M shares, 10.44%), Commodore capital lp (2.33M shares, 7.72%), and Millennium management (2.22M shares, 7.36%). Together, they hold 25.52% of AN2 Therapeutics’s total shares outstanding.

Does Blackrock own AN2 Therapeutics?

BlackRock is not among the top 10 institutional shareholders of AN2 Therapeutics.

Who is AN2 Therapeutics’s biggest shareholder by percentage of total assets invested?

Almitas capital is AN2 Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.14% of its assets in 1.48M AN2 Therapeutics shares, valued at 5.06M$.

Who is the top mutual fund holder of AN2 Therapeutics shares?

Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund holder of AN2 Therapeutics shares, with 2.37% of its total shares outstanding invested in 853.02K AN2 Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools